Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Objective Neurocognitive Assessment of Young Children With Sickle Cell Disease by Eye-Tracking

NCT07721155 is registered in ClinicalTrials.gov with Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) as lead sponsor.

NCT NCT07721155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07721155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Objective Neurocognitive Assessment of Young Children With Sickle Cell Disease by Eye-Tracking
Lead sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase
Observational
Overall status
Completed
Start date
March 16, 2023
Completion date
December 2, 2025
Enrollment
93 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurocognition, child, sickle cell, sickle cell disease